Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy (Q36222507)

12 August 2017

Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy (English)

1 reference

12 August 2017

anti-retroviral agent

0 references

1 reference

Jintanat Ananworanich

2

object named as

Jintanat Ananworanich

1 reference

12 August 2017

12

Jerome Kim

1 reference

12 August 2017

3

Victor Valcour

1 reference

12 August 2017

11

Linda Jagodzinski

1 reference

12 August 2017

9

Sasiwimol Ubolyam

1 reference

12 August 2017

13

Serena Spudich

1 reference

Somprartthana Rattanamanee

12 August 2017

10

object named as

Somprartthana Rattanamanee

1 reference

12 August 2017

5

Thep Chalermchai

1 reference

RV254/SEARCH010 Study Group

12 August 2017

14

object named as

RV254/SEARCH 010 Study Group

1 reference

12 August 2017

8

Somporn Tipsuk

1 reference

12 August 2017

Idil Kore

1

1 reference

12 August 2017

James L K Fletcher

4

1 reference

12 August 2017

Robert Paul

6

1 reference

12 August 2017

Jesse Reynolds

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 December 2015

1 reference

Journal of Acquired Immune Deficiency Syndromes

12 August 2017

1 reference

12 August 2017

70

1 reference

12 August 2017

4

1 reference

12 August 2017

393-399

1 reference

HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

The Impact of Depressive Symptoms on Neuropsychological Performance Tests in HIV-Infected Individuals: A Study of the Hawaii Aging with HIV Cohort.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Central nervous system viral invasion and inflammation during acute HIV infection

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

HIV-associated neurocognitive disorders: a historical review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Neurocognitive effects of HIV, hepatitis C, and substance use history

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Neurocognitive functioning in acute or early HIV infection

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Incidence and characterization of acute HIV-1 infection in a high-risk Thai population

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Immunopathogenesis of acute AIDS virus infection

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

A meta-analysis of the neuropsychological sequelae of HIV infection

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Decision-making speed in HIV-1 infection: a preliminary report

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

The prevalence and incidence of neurocognitive impairment in the HAART era.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4625393

Highly active antiretroviral therapy improves neurocognitive functioning

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26509933

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAI.0000000000000746

1 reference

12 August 2017

1 reference

12 August 2017

1 reference